Glenmark Pharmaceuticals Inc., USA recalls Ranolazine Extended-Release Tablets 500mg
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Dissolution Specifications: Out of specification for dissolution.
- Products
-
- Ranolazine Extended-Release Tablets 500mg
- Where it was sold
-
Nationwide
Nationwide
- Units affected
- 16,944 bottles
- About this recall
- Ranolazine Extended-Release Tablets 500mg, 60 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur Dist - Dhar, Madhya Pradesh - 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-319-60.